Saturday 17 October 2026
Export AVBP’s income statement to Excel — free account
ArriVent BioPharma, Inc.
AVBP Healthcare Biotechnology
In the quarter to June 2026, EPS fell 16.7% and free cash flow fell 51.5%, each against the same quarter a year earlier.
16.66
0.13
−0.77%
Follow AVBP
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | |
|---|---|---|---|---|---|
Current Ratio |
12.83 | 13.14 | 13.76 | 21.84 | 23.63 |
Net Debt/EBITDA |
1.73 | 2.32 | 2.02 | 4.43 | 0.72 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.97 | 0.87 | 0.81 | 1.18 | 0.24 |
Capex/Depreciation |
0.00 | — | — | — | — |
| (58.88%) | (154.10%) | 58.19% | 55.19% | 0.00% | |
| (54.70%) | (36.75%) | (40.08%) | (32.68%) | 0.00% | |
ROIC |
0.00% | (151.95%) | (5,134.22%) | (207.99%) | (818.42%) |
Return on Tangible Assets |
(54.18%) | (38.38%) | (46.74%) | (21.18%) | (125.46%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(4.18) | (2.23) | (26.08) | (34.17) | (17.70) |
Cash per Share |
8.13 | 6.95 | 70.24 | 127.93 | 52.43 |
Shareholders Equity per Share |
7.99 | 8.19 | 70.67 | 136.62 | 57.98 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.99 | 8.19 | 70.67 | 136.62 | 57.98 |
Free Cash Flow |
(160.59) | (70.21) | (55.84) | (43.63) | (12.59) |
Working Capital |
306.95 | 209.71 | 148.34 | 174.26 | 41.13 |
Net Current Asset Value |
306.95 | 209.69 | 148.17 | 174.25 | 41.13 |
| Other line items | |||||
Quick Ratio |
12.06 | 12.67 | 12.94 | 19.54 | 20.51 |
Depreciation/Fixed assets |
0.00 | — | — | — | — |
Cash ROIC |
(25.90%) | (14.73%) | (18.51%) | (12.91%) | (16.03%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(4.18) | (2.23) | (26.08) | (34.17) | (17.70) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
4.86 | 4.16 | 3.81 | 1.69 | — |
Average Assets |
304.06 | 219.02 | 172.97 | 112.94 | — |
Average Common Equity |
282.44 | 52.23 | (119.15) | (66.88) | — |
Columns are period end dates